Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Comparison of treatment outcomes of new smear-positive pulmonary tuberculosis patients by HIV and antiretroviral status in a TB/HIV clinic, Malawi.

Tweya H, Feldacker C, Phiri S, Ben-Smith A, Fenner L, Jahn A, Kalulu M, Weigel R, Kamba C, Banda R, Egger M, Keiser O.

PLoS One. 2013;8(2):e56248. doi: 10.1371/journal.pone.0056248. Epub 2013 Feb 15.

2.

The effect of HIV and antiretroviral therapy on characteristics of pulmonary tuberculosis in northern Malawi: a cross-sectional study.

Munthali L, Khan PY, Mwaungulu NJ, Chilongo F, Floyd S, Kayange M, Glynn JR, French N, Crampin AC.

BMC Infect Dis. 2014 Feb 25;14:107. doi: 10.1186/1471-2334-14-107.

3.

The burden and treatment of HIV in tuberculosis patients in Papua Province, Indonesia: a prospective observational study.

Pontororing GJ, Kenangalem E, Lolong DB, Waramori G, Sandjaja, Tjitra E, Price RN, Kelly PM, Anstey NM, Ralph AP.

BMC Infect Dis. 2010;10:362. doi: 10.1186/1471-2334-10-362. Epub 2010 Dec 24.

4.

Characteristics of adults and children diagnosed with tuberculosis in Lilongwe, Malawi: findings from an integrated HIV/TB clinic.

Feldacker C, Tweya H, Keiser O, Weigel R, Kalulu M, Fenner L, Egger M, Manda E, Mwafilaso JB, Kamba C, Phiri S.

Trop Med Int Health. 2012 Sep;17(9):1108-16. doi: 10.1111/j.1365-3156.2012.03041.x. Epub 2012 Jul 19.

5.

Healthcare provision for HIV co-infected tuberculosis patients in rural Zambia: an observational cohort study at primary care centers.

Miyano S, Muvuma S, Ishikawa N, Endo H, Msiska C, Syakantu G.

BMC Health Serv Res. 2013 Oct 8;13:397. doi: 10.1186/1472-6963-13-397.

6.

Timing of antiretroviral therapy and regimen for HIV-infected patients with tuberculosis: the effect of revised HIV guidelines in Malawi.

Tweya H, Ben-Smith A, Kalulu M, Jahn A, Ng'ambi W, Mkandawire E, Gabriel L, Phiri S.

BMC Public Health. 2014 Feb 20;14:183. doi: 10.1186/1471-2458-14-183.

8.

Clinical correlate of tuberculosis in HIV co-infected children at the University of Abuja Teaching Hospital, Gwagwalada, Nigeria.

Okechukwu AA, Okechukwu OI.

Niger J Clin Pract. 2011 Apr-Jun;14(2):206-11. doi: 10.4103/1119-3077.84018.

9.

Impact of the human immunodeficiency virus on early multidrug-resistant tuberculosis treatment outcomes in Botswana.

Hafkin J, Modongo C, Newcomb C, Lowenthal E, MacGregor RR, Steenhoff AP, Friedman H, Bisson GP.

Int J Tuberc Lung Dis. 2013 Mar;17(3):348-53. doi: 10.5588/ijtld.12.0100. Epub 2013 Jan 14.

10.

Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.

Louwagie G, Girdler-Brown B, Odendaal R, Rossouw T, Johnson S, Van der Walt M.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1052-8. doi: 10.5588/ijtld.11.0753. Epub 2012 Jun 12.

PMID:
22691870
11.

Mortality among tuberculosis patients in the Democratic Republic of Congo.

Henegar C, Behets F, Vanden Driessche K, Tabala M, Bahati E, Bola V, Van Rie A.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1199-204. doi: 10.5588/ijtld.11.0613.

PMID:
22871326
12.

Mortality associated with tuberculosis/HIV co-infection among patients on TB treatment in the Limpopo province, South Africa.

Mabunda TE, Ramalivhana NJ, Dambisya YM.

Afr Health Sci. 2014 Dec;14(4):849-54. doi: 10.4314/ahs.v14i4.12.

13.

Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.

Nagu TJ, Aboud S, Mwiru R, Matee MI, Rao M, Fawzi WW, Zumla A, Maeurer MJ, Mugusi F.

Int J Infect Dis. 2017 Mar;56:39-44. doi: 10.1016/j.ijid.2017.01.023. Epub 2017 Feb 1. Review.

14.

Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.

Kigozi G, Heunis C, Chikobvu P, Botha S, van Rensburg D.

Int J Infect Dis. 2017 Jan;54:95-102. doi: 10.1016/j.ijid.2016.11.407. Epub 2016 Nov 25.

15.

Tuberculosis among adults starting antiretroviral therapy in South Africa: the need for routine case finding.

Hanifa Y, Fielding KL, Charalambous S, Variava E, Luke B, Churchyard GJ, Grant AD.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1252-9. doi: 10.5588/ijtld.11.0733. Epub 2012 Jul 12.

PMID:
22794030
16.

Epidemiology of smear-negative pulmonary tuberculosis in the United States, 1993-2008.

Shah NS, Cavanaugh JS, Pratt R, Cain KP, Wells C, Laserson K, Nelson L.

Int J Tuberc Lung Dis. 2012 Sep;16(9):1234-40. doi: 10.5588/ijtld.11.0794. Epub 2012 Jun 28.

PMID:
22748057
17.

Prevalence of peripheral neuropathy in antiretroviral therapy naïve HIV-positive patients and the impact on treatment outcomes--a retrospective study from a large urban cohort in Johannesburg, South Africa.

Evans D, Takuva S, Rassool M, Firnhaber C, Maskew M.

J Neurovirol. 2012 Jun;18(3):162-71. doi: 10.1007/s13365-012-0093-2. Epub 2012 Apr 20.

PMID:
22528477
18.

Treatment outcome of HIV-associated tuberculosis in a resource-poor setting.

Ifebunandu NA, Ukwaja KN, Obi SN.

Trop Doct. 2012 Apr;42(2):74-6. doi: 10.1258/td.2011.110421.

PMID:
22431822
19.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
20.

Time to treatment and patient outcomes among TB suspects screened by a single point-of-care xpert MTB/RIF at a primary care clinic in Johannesburg, South Africa.

Hanrahan CF, Selibas K, Deery CB, Dansey H, Clouse K, Bassett J, Scott L, Stevens W, Sanne I, Van Rie A.

PLoS One. 2013 Jun 6;8(6):e65421. doi: 10.1371/journal.pone.0065421. Print 2013.

Supplemental Content

Support Center